137 related articles for article (PubMed ID: 2498124)
1. Hemolytic anemia and F. VIII concentrate.
Girelli G
Eur J Haematol; 1989 Apr; 42(4):414. PubMed ID: 2498124
[No Abstract] [Full Text] [Related]
2. [Severe serogenic hemolytic anemia caused by anti-D fraction in factor VIII concentrate].
Schricker KT; Schrenk KH
Thromb Diath Haemorrh; 1972 Jul; 27(3):523-8. PubMed ID: 4197045
[No Abstract] [Full Text] [Related]
3. Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.
Ewing NP
Prog Clin Biol Res; 1990; 324():59-68. PubMed ID: 2106693
[No Abstract] [Full Text] [Related]
4. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate.
Soni NS; Patel AR; Vohra RM; Shah PC
Acta Haematol; 1977; 58(5):294-7. PubMed ID: 413305
[TBL] [Abstract][Full Text] [Related]
5. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
[TBL] [Abstract][Full Text] [Related]
6. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate.
Williams MD; Skidmore SJ; Hill FG
Vox Sang; 1990; 58(2):135-6. PubMed ID: 2111060
[No Abstract] [Full Text] [Related]
7. Hemolytic anemia due to anti-B in antihemophiliac factor concentrates.
Ashenhurst JB; Langehennig PL; Seeler RA; Telfer MC
J Pediatr; 1976 Feb; 88(2):257-8. PubMed ID: 1249687
[No Abstract] [Full Text] [Related]
8. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
[TBL] [Abstract][Full Text] [Related]
9. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
Kessler CM; Ludlam CA
Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
[No Abstract] [Full Text] [Related]
10. Clotting factor concentrated--whither purity?
Thomas DP
Thromb Haemost; 1995 Dec; 74(6):1604-6. PubMed ID: 8772244
[No Abstract] [Full Text] [Related]
11. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
Seremetis SV
Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
[No Abstract] [Full Text] [Related]
12. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
[TBL] [Abstract][Full Text] [Related]
13. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
[No Abstract] [Full Text] [Related]
14. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Klukowska A; Zieleniewska B
Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
[TBL] [Abstract][Full Text] [Related]
15. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
[TBL] [Abstract][Full Text] [Related]
16. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
18. The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A.
Vlot AJ; Mauser-Bunschoten EP; Zarkova AG; Haan E; Kruitwagen CL; Sixma JJ; van den Berg HM
Thromb Haemost; 2000 Jan; 83(1):65-9. PubMed ID: 10669157
[TBL] [Abstract][Full Text] [Related]
19. The development and characterisation of antibodies to human factor VIII in haemophilic dogs.
Littlewood JD; Barrowcliffe TW
Thromb Haemost; 1987 Jun; 57(3):314-21. PubMed ID: 3116702
[TBL] [Abstract][Full Text] [Related]
20. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
